A deep dive into the intrinsic value of Aurelius Technologies Berhad (KLSE:ATECH) using a Discounted Cash Flow model suggests a potential disconnect between its market price and fundamental valuation, raising questions for investors.
As XPeng shares face sustained pressure, a deep dive into its valuation reveals a stark contradiction: while a fundamental cash flow model suggests significant upside, market-based metrics paint a more cautious picture. We analyze the numbers behind the divergence.
SanDisk's Q2 2026 earnings reveal a 31% sequential revenue surge to $3 billion, driven by AI infrastructure build-out. The company highlights a fundamental industry shift towards long-term agreements as data center demand, now the largest NAND market, reshapes commercial dynamics.
Amidst a strategic merger with New Gold and a multi-year production expansion plan, Coeur Mining emerges as a compelling North American precious metals play. Analysts point to a significant gap between its current market valuation and underlying fundamentals.
Amidst a mixed Asian market landscape, companies with significant insider ownership are drawing investor attention. We examine three high-growth firms from South Korea and China where executives and directors have substantial skin in the game.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
The narrative around Chinese electric vehicles is undergoing a fundamental shift. Once known primarily for affordability, leading Chinese automakers are now challenging incumbents with rapidly improving quality, technology, and reliability, forcing a global industry recalibration.
Google's unveiling of Project Genie, an AI tool for generating interactive 3D worlds, sends ripples through the game development sector, directly challenging incumbent platform Unity Software. The announcement coincides with a period of intense volatility and investor scrutiny for Unity, raising fundamental questions about its long-term strategic position in an AI-driven landscape.
Despite both tech giants aggressively investing in AI, their stock prices are telling divergent stories. We examine the underlying fundamentals that make them resilient picks for any portfolio, regardless of short-term volatility.
As investors navigate a complex economic landscape, companies with significant insider ownership and robust earnings forecasts are drawing attention. We examine three ASX-listed firms where leadership's skin in the game aligns with ambitious growth projections.
The quiet maneuvering between Carlyle Group, Russia's Lukoil, and the UAE reveals a fundamental shift in global energy finance. As Western sanctions redraw the map, a new playbook is emerging—one where assets are restructured, risks are repackaged, and geopolitical neutrality becomes a tradable commodity.
The surge in popularity of weight-loss drugs like Ozempic and Wegovy is sending shockwaves far beyond the pharmacy, fundamentally altering consumer spending, challenging major corporations, and forcing a broad economic recalibration.
Fresh financial data from QuidelOrtho reveals ongoing challenges, including constant currency revenue declines and pressured cash flow, forcing investors to weigh the stock's risk-reward profile as its momentum appears to fade.
As the TSX rides a wave of positive earnings momentum, adventurous investors are turning their gaze to the penny stock arena. We analyze three micro-cap companies—Automotive Finco, Aurora Spine, and Wilton Resources—that are generating buzz, weighing their potential against significant financial risks.
Amidst a resilient market backdrop, we spotlight three U.S. stocks trading significantly below their estimated intrinsic value, offering potential for investors willing to navigate current volatility.
As the 2027 deadline for Swift's Case Management standard approaches, banks face a strategic inflection point. Early adopters of native processing are poised to unlock operational resilience and revenue growth, while laggards risk entrenched inefficiency and competitive decline.
Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.
NETSTREIT Corp. (NYSE: NTST) has delivered impressive shareholder returns over the past year, significantly outpacing its longer-term performance. As the stock hovers near $19, investors and analysts are debating whether its current price fully reflects the fundamentals of this necessity-based retail REIT or if momentum has gotten ahead of value.
First Pacific Advisors' FPA Crescent Fund disclosed it sold its position in tech giant Microsoft in Q4 2025. The value-focused fund explained the move was driven by a search for greater upside in other AI-related investments, despite acknowledging Microsoft's strong fundamentals.
